Items where the Publication is European Journal of Heart Failure
Number of items: 4.
2022
Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER-like endpoint definitions. (2022)
Anker, Stefan D; Siddiqi, Tariq Jamal; Filippatos, Gerasimos; Zannad, Faiez; Ferreira, João Pedro; Pocock, Stuart J; Brueckmann, Martina; Zeller, Cordula; Packer, Milton; Butler, Javed
Early benefit with empagliflozin in heart failure with preserved ejection fraction: insights from the EMPEROR-Preserved trial. (2022)
Butler, Javed; Siddiqi, Tariq Jamal; Filippatos, Gerasimos; Ferreira, João Pedro; Pocock, Stuart J; Zannad, Faiez; Anker, Stefan D
Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank. (2022)
Rastogi, Tripti; Ho, Frederick K; Rossignol, Patrick; Merkling, Thomas; Butler, Javed; Clark, Andrew; Collier, Timothy; Delles, Christian; Jukema, J Wouter; Heymans, Stephane; Latini, Roberto; Mebazaa, Alexandre; Pellicori, Pierpaolo; Sever, Peter; Staessen, Jan A; Thijs, Lutgarde; Cleland, John G; Sattar, Naveed; Zannad, Faiez; Girerd, Nicolas
2019
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF). (2019)
McMurray, John JV; DeMets, David L; Inzucchi, Silvio E; Køber, Lars; Kosiborod, Mikhail N; Langkilde, Anna M; Martinez, Felipe A; Bengtsson, Olof; Ponikowski, Piotr; Sabatine, Marc S; Sjöstrand, Mikaela; Solomon, Scott D; DAPA-HF Committees and Investigators
